A5248 - First-phase Viral Decay Rates in Treatment-NaÏve Subjects Initiating Treatment with Raltegravir (RAL) and Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF): A Pilot Study

Study Status: Coming soon.